GVGH-Sal: 06CARB-X968; A combination vaccine for sustainable prevention of invasive Salmonelloses in sub-Saharan Africa
IATI Identifier: US-EIN-04-2103547-GSK Bio Sal
Published on
- date_range Oct 01, 2020 - Dec 31, 2024
- autorenew Implementation (Status)
- mail Contact
- share Share
TBD
more_horiz
Sectors:
-
Infectious disease control
Participating Organisations
| Name | Type | Role |
|---|---|---|
| GSK Bio | Private Sector | Implementing |
Transaction
| Transaction Value |
Provider
Receiver |
Type | Date |
|---|---|---|---|
| 66,036 USD (Valued at Jun 08, 2023) | Provider N/A Receiver N/A | Expenditure |
date_range
Jun 08, 2023
|
| 541,483 USD (Valued at Apr 25, 2022) | Provider N/A Receiver N/A | Expenditure |
date_range
Apr 25, 2022
|
Budget
607,519
USD
-
541,483 USD (Valued at Jul 22, 2021)date_range Oct 01, 2020 - Jul 31, 2021
-
66,036 USD (Valued at Jun 08, 2023)date_range Jul 01, 2022 - Jun 30, 2023
access_time
Updated on
Jun 08, 2023 20:14:06